Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
1.382
Zitationen
10
Autoren
2002
Jahr
Abstract
Caspofungin is at least as effective as amphotericin B for the treatment of invasive candidiasis and, more specifically, candidemia.
Ähnliche Arbeiten
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
2008 · 4.897 Zit.
Hidden Killers: Human Fungal Infections
2012 · 4.263 Zit.
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 · 4.141 Zit.
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 · 3.953 Zit.
J Antimicrob Chemother 1994; 33: 350–351
1994 · 3.753 Zit.